Q4 2024 · 13F-HR
BIOS Capital Management, LPholdings as filed
Filed 2025-02-10 · accession 0001104659-25-010964
$95.9M
Reported value
6
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 005083100 | ACTU | ACTUATE THERAPEUTICS INC | $78.8M | 82.1% | 9,893,651 | Common | SHARED |
| 19243B102 | CGTX | COGNITION THERAPEUTICS INC | $4.2M | 4.39% | 6,000,000 | Common | SHARED |
| 00887A204 | RNTX | AILERON THERAPEUTICS INC | $3.9M | 4.06% | 1,690,751 | Common | SHARED |
| 51654W101 | LTRN | LANTERN PHARMA INC | $3.9M | 4.02% | 1,207,709 | Common | SHARED |
| 67577R102 | IRD | OPUS GENETICS INC | $3.0M | 3.08% | 2,480,983 | Common | SHARED |
| 45674E109 | INABEUR | IN8BIO INC | $2.2M | 2.31% | 8,600,001 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.